Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.43 |
| ▸ | PPARG | P37231 | 3/20 | 0.43 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | RXRA | P19793 | 2/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.43 |
| ▸ | PPARA | Q07869 | 3/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.40 |
| ▸ | F7 | P08709 | 3/20 | 0.40 |
| ▸ | F3 | P13726 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | PPARD | Q03181 | 2/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2363268 | 1.00 | ALDH1A1 (0.43) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL19751288 | 1.00 | ALDH1A1 (0.43) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL532114 | 0.89 | PPARA (0.43) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL351756 | 0.89 | ALDH1A1 (0.56) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL532113 | 0.89 | PPARA (0.43) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL351755 | 0.89 | ALDH1A1 (0.56) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL6473962 | 0.86 | — | — | |
| SCHEMBL6478764 | 0.86 | — | — | |
| SCHEMBL2120659 | 0.86 | — | — | |
| SCHEMBL2120663 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11649348-B2 | Resin composition and medical drug container using same | ZEON CORPORATION (JP) | 2023-05-16 | — | — | US | claimed |
| CN-108138088-A | For the particle of stench reduction | 宝洁公司 | 2018-06-08 | — | — | CN | claimed |
| CN-107073153-A | The product of material is reduced comprising stench | 宝洁公司 | 2017-08-18 | — | — | CN | claimed |
| CN-106714849-A | Substrates comprising malodor reduction compositions | 宝洁公司 | 2017-05-24 | — | — | CN | claimed |
| JP-11060971-A | — | — | None | — | — | JP | disclosed |
| US-12595359-B2 | Resin composition for forming optical component, molded product, and optical component | MITSUI CHEMICALS, INC. (JP) | 2026-04-07 | — | — | US | disclosed |
| EP-4692228-A1 | RESIN COMPOSITION AND MOLDED BODY | Zeon Corporation (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-12509489-B2 | Oligopeptide | ZEON CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| US-20250388841-A1 | WELL PLATE AND CULTURE METHOD | MITSUI CHEMICALS, INC. (JP) | 2025-12-25 | — | — | US | disclosed |
| US-20250215125-A1 | CYCLIC OLEFIN-BASED RESIN COMPOSITION, VARNISH, CROSSLINKED BODY, FILM, SHEET, CIRCUIT BOARD, ELECTRONIC APPARATUS, AND PREPREG | MITSUI CHEMICALS, INC. (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250179232-A1 | RESIN COMPOSITION, MOLDED PRODUCT, AND OPTICAL MEMBER | ZEON CORPORATION (JP) | 2025-06-05 | — | — | US | disclosed |
| WO-2025084431-A1 | SURFACE TREATMENT AGENT, SURFACE TREATMENT AGENT KIT, SURFACE-MODIFIED MOLDED ARTICLE, AND METHOD FOR PRODUCING SURFACE-MODIFIED MOLDED ARTICLE | 日本ゼオン株式会社 | 2025-04-24 | — | — | WO | disclosed |
| US-20030021889-A1 | Method for manufacturing multilayer circuit board | ZEON CORPORATION (JP) | 2003-01-30 | — | — | US | disclosed |
| US-6511756-B1 | Impact resistance; chemical and weather resistance; flexible; transparent; carport and housing exteriors, food packaging films, optical lenses, electrical wiring and power cable wrapping | NIPPON ZEON CO., LTD. (JP) | 2003-01-28 | — | — | US | disclosed |
| EP-1268499-A1 | METHOD FOR POLYMERIZING POLAR SUBSTITUTED CYCLOALKENES | Bayer Aktiengesellschaft (DE) | 2003-01-02 | — | — | EP | disclosed |
| WO-2001072760-A1 | METHOD FOR POLYMERIZING POLAR SUBSTITUTED CYCLOALKENES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-10-04 | — | — | WO | disclosed |
| EP-1123869-A2 | CONTAINER AND BLOW-MOLDED PRODUCT | NIPPON ZEON CO., LTD. (JP) | 2001-08-16 | — | — | EP | disclosed |
| EP-1026189-A1 | THERMOPLASTIC DICYCLOPENTADIENE-BASE OPEN-RING POLYMERS, HYDROGENATED DERIVATIVES THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH | Nippon Zeon Co., Ltd. (JP) | 2000-08-09 | — | — | EP | disclosed |
| JP-H1160971-A | THERMOPLASTIC HYDROCARBON POLYMER COMPOSITION | NIPPON ZEON CO LTD | 1999-03-05 | — | — | JP | disclosed |
| EP-0084795-B1 | A PROCESS OF RECOVERING ALKALI METAL-TERMINATED RESINOUS COPOLYMERS | PHILLIPS PETROLEUM COMPANY (US) | 1988-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595359-B2 | Resin composition for forming optical component, molded product, and optical component | ASIC1, NLRP1, ASIC3 | ALDH1A1 744/4885CYP19A1 1956/4885PPARG 3982/4885 |
| US-20250388841-A1 | WELL PLATE AND CULTURE METHOD | LCP1, CD14, TLL2 | ALDH1A1 3735/4885CYP19A1 4119/4885PPARG 2474/4885 |
| US-12509489-B2 | Oligopeptide | FN1, HGF, TNFSF11 | ALDH1A1 2346/4885CYP19A1 4411/4885PPARG 4601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.